{"disease":{"id":"relapsed-refractory-hematopoietic-malignancies-acute-myeloid-leukemia-and-mds","name":"relapsed refractory hematopoietic malignancies acute myeloid leukemia and mds"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02203903","title":"Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Catherine Bollard","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}